Questions remain over Canada's vaccination drive amid delays and fresh applications
Canada's national vaccine rollout seems poised to dominate COVID-19 discussions in the coming week as Canada enters the 11th month of life during a global pandemic.
The federal government, which is overseeing the nationwide effort, has been facing strong criticism as it struggles to ensure there are enough immunization doses to go around.
The two companies whose vaccines have been approved for use here recently complicated matters by saying they wouldn't immediately be able to deliver their promised number of doses due to production delays in Europe.
The Liberal government has repeatedly said both Pfizer-BioNTech and Moderna still intend to fulfill their promised delivery schedules and that current delays are temporary.
At least three other companies, Novavax, Astra-Zeneca and Johnson and Johnson, have all launched the process of having Health Canada approve their vaccines.
Canada officially recorded more than 20,000 deaths caused by COVID-19 as of Sunday and is still logging high daily case counts in several provinces, though Chief Public Health Officer Dr. Theresa Tam says overall totals are trending downward.